It Ain't Soda
This article was originally published in RPM Report
Executive Summary
Least Costly Alternative sounds like a reasonable middle way between uncontrolled spending on medicine and overt price controls. But "alterantives" are in the eye of the beholder. Industry should start now to make sure that any move towards LCA takes into account the important differences between similar medicines.